Assays Featured Articles

  1. New Nanoparticles Shrink Tumors In Mice 8/16/2012

    MIT researchers have developed RNA-delivering nanoparticles that allow for rapid screening of new drug targets in mice. In their first mouse study, done with researchers at Dana-Farber Cancer Institute and the Broad Institute, they showed that nanoparticles that target a protein known as ID4 can shrink ovarian tumors.  

  2. Engineered Tissue Vary Depending On Where It's Grown 8/16/2012

    MIT researchers led by Elazer Edelman, the Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology, have now shown that implanted cells’ therapeutic properties depend on their shape, which is determined by the type of scaffold on which they are grown. 

  3. CeeTox and Cellular Dynamics Collaborate To Offer Predictive In Vitro Test for Cardiotoxicity 8/15/2012

    CeeTox and Cellular Dynamics announced the introduction of a new, highly predictive cardiac safety screening service that utilizes human induced pluripotent stem (iPS) cell-derived cardiomyocytes. 

  4. Success Of Engineered Tissue Depends On Where It's Grown 8/14/2012

    Tissue implants made of cells grown on a sponge-like scaffold have been shown in clinical trials to help heal arteries scarred by atherosclerosis and other vascular diseases. However, it has been unclear why some implants work better than others. By Anne Trafton

  5. GE Healthcare Launches FF High Performance Nitrocellulose Membranes Optimized For Diagnostic Assay Reproducibility 8/1/2012

    GE Healthcare Life Sciences’ new Whatman FF High Performance (HP) membrane provides the industry with a new diagnostic membrane to enable fast, razor-sharp line separation and highly reproducible results for the detection of target molecules in liquids such as water, urine, blood and saliva.

  6. Stago Launches Products For Measurement Of Rivaroxaban 7/16/2012

    The STA – Rivaroxaban Calibrator and Controls are highly specific, automation-ready products for determining the rivaroxaban concentration in plasma when used in conjunction with the STA - Liquid Anti-Xa assay.

  7. BINDER ANTI.PLENUM CO2 Incubators Reduce Threat Of Contamination 6/11/2012

    BINDER CO2 incubators with ANTI.PLENUM design reduce the probability of contamination in the unit interior by a factor of three. The deep-drawn inner chamber with integrated shelf fixtures and large, rounded corners, the core of the design, provides such additional benefits as ease of care and reduced overall expenses.

  8. Thermo Fisher Scientific Introduces Next-Generation Benchtop LC-MS System At ASMS 2012 5/21/2012

    Thermo Fisher Scientific Inc., the world leader in serving science, recently announced the Thermo Scientific Exactive Plus system, the company’s latest benchtop liquid chromatography-mass spectrometry (LC-MS) system for high-throughput screening, identification and quantification of compounds in complex matrices.

  9. Evotec Becomes The First Contract Research Facility In Europe To Offer Agilent's RapidFire/MS Screening For Pharmaceutical Drug Discovery 5/16/2012

    Evotec AG is proud to announce the addition of Agilent Technologies' RapidFire Mass Spectrometry analysis capabilities to their High Throughput Screening facilities in Hamburg.

  10. IntelligentMDx Announces CE-Marking Of A New High-Throughput Test For Group B Streptococcus Intended To Improve Women's Health And Prenatal Care 5/15/2012

    IntelligentMDx (IMDx) announced recently that it has obtained CE-marking for a new automated, high-throughput, qualitative in vitro diagnostic test designed for the rapid detection of Group B Streptococcus (GBS) for use in screening pregnant women and those in labor who may be infected with the pathogen.